Friday, June 19, 2020
7:00 AM – 8:00 AM ET
Please note this Virtual program is at 7:00AM Eastern, 6:00AM Central, 5:00AM Mountain, and 4:00AM Pacific.
Lucia Diaz, M.D.
Assistant Professor, Department of Pediatrics
Associate Program Director, Dermatology Residency
The University of Texas at Austin
After completing the CME activity, learners should be better able to:
- Employ diagnostic best practices for pediatric patients with moderate to severe AD and incorporate severity assessment tools to guide patient management decisions
- Review the clinical profiles, including sensory tolerability issues such as application site pain, and mechanisms of action of established and newly approved and emerging agents for the treatment of pediatric patients with moderate to severe AD
- Design individualized treatment plans for pediatric patients with AD that incorporate specific patient factors, current evidence-based guidance, and the clinical profiles of new and emerging treatments
- Examine the benefits associated with pediatric patient-centered, team-based, shared decision-making approaches for the management of moderate to severe AD
This activity is intended educate PCPs, NPs, and PAs about diagnosing, treating, and managing atopic dermatitis in pediatric patients.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSING CREDIT INFORMATION
This program would be beneficial for nurses involved in the care of patients with atopic dermatitis.
1.0 ANCC Contact Hour(s)
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at email@example.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.